Paperpal Prime Logo

American Journal of Clinical Dermatology : Impact Factor & More

eISSN: 1179-1888pISSN: 1175-0561

Key Metrics

CiteScore
12.1
Impact Factor
5 - 10
SJR
Q1Dermatology
SNIP
3.02
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on American Journal of Clinical Dermatology

American Journal of Clinical Dermatology Journal Specifications

Overview
Publisher ADIS INT LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2000
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in American Journal of Clinical Dermatology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in American Journal of Clinical Dermatology

Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.
  • 7 Aug 2026
  • American journal of clinical dermatology
Systemic Comorbidities of Keloid and Hypertrophic Scars: A Phenome-Wide Association Study in a Multiethnic U.S. Pediatric Cohort.
  • 2 Aug 2026
  • American journal of clinical dermatology
Correction to: Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies.
  • 28 Jul 2026
  • American journal of clinical dermatology
Efficacy and Safety of Oral Janus Kinase Inhibitors in Adults and Adolescents with Alopecia Areata: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
  • 28 Jul 2026
  • American journal of clinical dermatology
Updated Integrated Safety Analysis of Ritlecitinib up to ~5Years in Patients with Alopecia Areata from the ALLEGRO Clinical Trial Program.
  • 22 Jul 2026
  • American journal of clinical dermatology
A Systematic Review of Factors Influencing Adult Adherence to Topical Medications in Atopic Dermatitis.
  • 9 Jul 2026
  • American journal of clinical dermatology
Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.
  • 7 Aug 2026
  • American journal of clinical dermatology
Systemic Comorbidities of Keloid and Hypertrophic Scars: A Phenome-Wide Association Study in a Multiethnic U.S. Pediatric Cohort.
  • 2 Aug 2026
  • American journal of clinical dermatology
Correction to: Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies.
  • 28 Jul 2026
  • American journal of clinical dermatology
Efficacy and Safety of Oral Janus Kinase Inhibitors in Adults and Adolescents with Alopecia Areata: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
  • 28 Jul 2026
  • American journal of clinical dermatology
Updated Integrated Safety Analysis of Ritlecitinib up to ~5Years in Patients with Alopecia Areata from the ALLEGRO Clinical Trial Program.
  • 22 Jul 2026
  • American journal of clinical dermatology
A Systematic Review of Factors Influencing Adult Adherence to Topical Medications in Atopic Dermatitis.
  • 9 Jul 2026
  • American journal of clinical dermatology

FAQs on American Journal of Clinical Dermatology